Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Platelet aggregation monitoring with a newly developed quartz crystal microbalance system as an alternative to optical platelet aggregometry.

Sinn S, Müller L, Drechsel H, Wandel M, Northoff H, Ziemer G, Wendel HP, Gehring FK.

Analyst. 2010 Nov;135(11):2930-8. doi: 10.1039/c0an00474j. Epub 2010 Sep 29.

PMID:
20877907
2.

The use of quartz crystal microbalance with dissipation (QCM-D) for studying nanoparticle-induced platelet aggregation.

Santos-Martinez MJ, Inkielewicz-Stepniak I, Medina C, Rahme K, D'Arcy DM, Fox D, Holmes JD, Zhang H, Radomski MW.

Int J Nanomedicine. 2012;7:243-55. doi: 10.2147/IJN.S26679. Epub 2012 Jan 13.

3.

NCO-sP(EO-stat-PO) coatings on gold sensors--a QCM study of hemocompatibility.

Sinn S, Eichler M, Müller L, Bünger D, Groll J, Ziemer G, Rupp F, Northoff H, Geis-Gerstorfer J, Gehring FK, Wendel HP.

Sensors (Basel). 2011;11(5):5253-69. doi: 10.3390/s110505253. Epub 2011 May 13.

4.

Pharmacological characterization of nanoparticle-induced platelet microaggregation using quartz crystal microbalance with dissipation: comparison with light aggregometry.

Santos-Martinez MJ, Tomaszewski KA, Medina C, Bazou D, Gilmer JF, Radomski MW.

Int J Nanomedicine. 2015 Aug 13;10:5107-19. doi: 10.2147/IJN.S84305. eCollection 2015.

5.

Rapid assessment of platelet function with a modified whole-blood aggregometer in percutaneous transluminal coronary angioplasty patients receiving anti-GP IIb/IIIa therapy.

Mascelli MA, Worley S, Veriabo NJ, Lance ET, Mack S, Schaible T, Weisman HF, Jordan RE.

Circulation. 1997 Dec 2;96(11):3860-6.

6.

Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.

Gawaz M, Ruf A, Pogatsa-Murray G, Dickfeld T, Rüdiger S, Taubitz W, Fischer J, Müller I, Meier D, Patscheke H, Schömig A.

Thromb Haemost. 2000 Jun;83(6):915-22.

PMID:
10896249
7.

An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregates.

Marciniak SJ Jr, Mascelli MA, Furman MI, Michelson AD, Jakubowski JA, Jordan RE, Marchese PJ, Frelinger AL.

Thromb Haemost. 2002 Jun;87(6):1020-5.

PMID:
12083481
8.

Utilisation of Quartz Crystal Microbalance Sensors with Dissipation (QCM-D) for a Clauss Fibrinogen Assay in Comparison with Common Coagulation Reference Methods.

Oberfrank S, Drechsel H, Sinn S, Northoff H, Gehring FK.

Sensors (Basel). 2016 Feb 24;16(3):282. doi: 10.3390/s16030282.

10.

The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation.

Straub A, Wendel HP, Azevedo R, Ziemer G.

Eur J Cardiothorac Surg. 2005 Apr;27(4):617-21. Epub 2005 Jan 13.

PMID:
15784360
11.

Abciximab is rapidly effective in preventing and arresting established platelet aggregation.

Dalby MC, Davidson SJ, Burman JF, Sigwart U, Davies SW.

J Thromb Thrombolysis. 2002 Jun;13(3):141-5.

PMID:
12355030
12.

Rapid platelet-function assay: an automated and quantitative cartridge-based method.

Smith JW, Steinhubl SR, Lincoff AM, Coleman JC, Lee TT, Hillman RS, Coller BS.

Circulation. 1999 Feb 9;99(5):620-5.

13.

Activation of platelets in platelet-rich plasma by rotablation is speed-dependent and can be inhibited by abciximab (c7E3 Fab; ReoPro).

Williams MS, Coller BS, Väänänen HJ, Scudder LE, Sharma SK, Marmur JD.

Circulation. 1998 Aug 25;98(8):742-8.

14.
15.
16.

Testing platelet activation with a shear-dependent platelet function test versus aggregation-based tests: relevance for monitoring long-term glycoprotein IIb/IIIa inhibition.

Osende JI, Fuster V, Lev EI, Shimbo D, Rauch U, Marmur JD, Richard M, Varon D, Badimon JJ.

Circulation. 2001 Mar 20;103(11):1488-91.

17.
18.
19.

Evaluation of platelet function, a method comparison.

Nylander S, Johansson K, Van Giezen JJ, Lindahl TL.

Platelets. 2006 Feb;17(1):49-55.

PMID:
16308187
20.

Acoustic detection of cell adhesion to a coated quartz crystal microbalance - implications for studying the biocompatibility of polymers.

Da-Silva AC, Soares SS, Ferreira GN.

Biotechnol J. 2013 Jun;8(6):690-8. doi: 10.1002/biot.201200320. Epub 2013 Apr 11.

PMID:
23447442

Supplemental Content

Support Center